Development of long in vivo tissue-engineered "Biotube" vascular grafts.
Sign Up to like & getrecommendations! Published in 2018 at "Biomaterials"
DOI: 10.1016/j.biomaterials.2018.09.032
Abstract: In-body tissue architecture (iBTA), a cell-free, in vivo tissue engineering technology that can produce autologous implantable tissues of the desired shape by subcutaneously embedding specially designed molds, was used to develop long tubular collagenous tissues… read more here.
Keywords: development long; vascular grafts; long vivo; tissue ... See more keywords
TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-life
Sign Up to like & getrecommendations! Published in 2023 at "mAbs"
DOI: 10.1080/19420862.2022.2160229
Abstract: ABSTRACT TrYbe® is an Fc-free therapeutic antibody format, capable of engaging up to three targets simultaneously, with long in vivo half-life conferred by albumin binding. This format is shown by small-angle X-ray scattering to be… read more here.
Keywords: vivo half; trybe free; half life; long vivo ... See more keywords